Browsing Tag
ONS-5010
1 post
Outlook Therapeutics Faces Setback as FDA Rejects ONS-5010 Treatment
Shares of Outlook Therapeutics (OTLK) took a nosedive in premarket trading today, plummeting over 60%. This significant drop…
Browsing Tag
ONS-5010
1 post